NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed Sep 12, 2013
Insider Transaction Report
Form 4
Snell Todd M
SVP, QA, Reg.&Clinical Affairs
Transactions
- Sale
Common Stock
2013-09-10$12.62/sh−427$5,389→ 6,049 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2012.